trending Market Intelligence /marketintelligence/en/news-insights/trending/i1uol4vl3utrhobif0c36q2 content esgSubNav
In This List

Zynex to buy back $2M of common stock

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Zynex to buy back $2M of common stock

Zynex, Inc. said its board approved a stock back program for an additional $2 million of the company's common stock.

The Englewood, Colo.-based developer of electrotherapy medical devices said the program will begin May 14 and terminate May 13, 2019, or when the $2 million buyback limit is reached.

Zynex expects to finance the share buyback with existing cash balances.

The company had undertaken a buyback program from Dec. 6, 2017, through March 6. It repurchased 495,091 common shares.